Dr. Roberto Galea and Dr. C. Michael Gibson Discuss: One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial October 24, 2023 Disclosures: TBD
Dr. Michael J. Reardon and Dr. C. Michael Gibson Discuss: Four-Year Outcomes From the EVOLUT Low Risk Trial October 24, 2023 Disclosures: TBD
Dr. Erlend Berg and Dr. C. Michael Gibson Discuss: After Eighty Study – Long-Term Outcomes of an Invasive versus Conservative Strategy in Stabilised Patients Aged 80 Years or Older With Non-ST-Elevation Acute Coronary Syndrome, After Eighty Study: A Randomised Controlled Trial November 7, 2022 Disclosures: TBD
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2022 Daily Wrap-Up – September 19, 2022 September 19, 2022 Disclosure: TBA
Dr. Pablo Salinas and Dr. Yazan Daaboul Discuss: Two-Year Outcomes Of The Randomized Second-Generation Drug-Eluting Stents In Diabetes (SUGAR) Trial September 19, 2022 Disclosure: TBA
Dr. Toshiro Shinke and Dr. C. Michael Gibson Discuss: Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry) September 19, 2022 Disclosure: TBA
Dr. Antonio Mangieri and Dr. C. Michael Gibson Discuss: Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial September 19, 2022 Disclosure: TBA
Dr. Shamir Mehta and Dr. C. Michael Gibson Discuss: Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction September 19, 2022 Disclosure: TBA
Dr. Lei Song and Dr. C. Michael Gibson Discuss: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: Two-Year Outcomes of the FAVOR III China Trial September 19, 2022 Disclosure: TBA
Dr. Zsolt Piroth and Dr. Yazan Daaboul Discuss: FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs. Functional Significance and Prognostic Value of Post-PCI FFR September 19, 2022 Disclosure: TBA
